ESOPEC results A new standard of care in #esophagealcancer #asco24

ESOPEC PFS results 14% ⬆️ in 5 year PFS. FLOT cured more than CROSS #ASCO24

2. #TransMet: Chemo + Liver transplant vs Chemo in metastatic liver confined CRC: - mFU of 59 mos, ⬆️ PFS 57% vs 13% (HR: 0.37) - OS: 73% vs 9% (HR: 0.16) - Importance of Multi-D for liver confined disease #crcsm 3/9

ASCO interested in #cachexia? Swing by poster 336 to geek out #symptomscience #PallOnc ⁦Richard Dunne, MD⁩ ⁦MASCC⁩

#Yoga & cognitive behavioral therapy reduce cancer-related fatigue by improving sleep in cancer survivors Awesome presentation by Po-Ju Lin, PhD, MPH, RD of Wilmot Cancer Institute #ASCO24

42 out of 42 complete responses with dostarlimab. No local regrowths seen yet Curing rectal cancer without chemo, radiation or surgery 👏👏 #Asco24 #crcsm

🤩Efrat Dotan MD presents NCI CTEP Clinical Research @EAOnc EA2186: Randomized Phase II Gem/Nab-Paclitaxel vs. 5-FU/LV/ Liposomal Irinotecan in Older Pts with Tx-Naive Met Pancreatic Cancer (GIANT) #asco24 ASCO #cancer #cancerresearch noted NS difference in OS but demonstrates the imp of

NIVO + IPI vs LEN (90%) or SORA as 1st line treatment for HCC #ASCO24 🤩Exciting times: More & more options in 1st line HCC 💪Clear improvement in OS with ICI based therapy & sequential therapy 🎯Now, we need biomarkers to guide treatment decisions ESMO - Eur. Oncology @ILCA @EASL

We hope to see you during Black Family Cancer Awareness Week for a conversation with Dr. Marcus Noel! On Thursday, June 27, 2024 at 11 a.m. PT/2 p.m. ET, he'll be answering your questions about #pancreaticcancer, with a special focus on the disparities experienced by the Black

💡 New review published today in Nature Reviews Cancer. An important part of this piece about mortality in cancer patients is the role of cachexia, highlighted by members of #CancerGrandChallenges team CANCAN Tobias Janowitz and Mariam Jamal-Hanjani. Read 👇 nature.com/articles/s4156…

Collaboration with Cancer and Aging Research Group (CARG) #GeriOnc buddy and super star Surbhi Singhal on #nutrition #psychologicalhealth and #qol in #gerionc SIOG onlinelibrary.wiley.com/doi/10.1002/ca… Wilmot Cancer Institute URMC Department of Medicine

GI Malignancy Highlights from #ASCO24 w/ Mark Lewis, MD, FASCO - #ESOPEC - #ARMANI - #TRANSMET - #COLLISION - #COMMIT Full Int: - Oncbrothers.com/asco24-gi - targetedonc.com/data-dialogue-… - Also on the “Oncology Brothers” podcast #gism ASCO #OncTwitter #MedTwitter Targeted Oncology

Can’t wait for the inaugral Integrity CE, LLC Wilmot Cancer Institute Roswell Park Upstate NY Cancer Symposium! 1.5 days to focus on the current SoC and updates from #ASCO24 in commonly treated solid + hematologic malignancies! #OncTwitter #MedTwitter

Welcome to Wilmot! 👋 As a proud host site for ASCO Oncology Summer Internship program, aimed at strengthening diversity in oncology, we welcomed 9 students (7 pictured), a record for us! We're excited to have these URochester SMD students with us for the next few weeks.

"Our study also raises a potential health risk of the Keto diet in human patients with cancer." science.org/doi/10.1126/sc…

As one of the co-Chairs w/ Drs. Martine Puts and Shabbir Alibhai, I am so happy with the preliminary agenda: SIOG 2024 Annual Conference – Online programme now available: mailchi.mp/siog.org/siog-…. Thread on why to attend SIOG 2024!

I'm interested in connecting with anyone that runs a cachexia-specific clinic. If you haven't already heard from me by email could you please send me a DM?

Useful literature review from Richard Dunne, MD Wilmot Cancer Institute & colleagues on #cachexia incidence & impact on survival in #PancreaticCancer & #ColorectalCancer onlinelibrary.wiley.com/doi/10.1002/jc… Pancreatic cancer data below across reviewed studies. Important citation for cachexia researchers.

"Every older adult deserves personalized care, and geriatric assessment is key to making that happen." - Allison Magnuson, DO, MS & Melissa (Kah Poh) Loh, MBBCh BAO, MS, FACCC of Wilmot Cancer Institute Access new guidance on #GeriatricAssessment for clinicians: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… Supriya Mohile OncoAlert #GeriOnc

Retrospective series of short v long course RT in rectal cancer Despite achieving similar rates of complete response (~44%), organ preservation w LC better (2yr 40% v 31%) German AIO18.1 RCT to provide definitive data, but for now LC TNT remains preferred reg for non-op intent